Last reviewed: July 3, 2026
Last updated: July 3, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Yes, Wegovy is administered as a once-weekly subcutaneous injection containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. Clinical trials show that injectable semaglutide produces an average weight loss of 15% of body weight over 68 weeks in adults with obesity. PlexusDx provides access to compounded semaglutide injections at a fraction of brand-name costs, with pricing that remains stable regardless of your dose level.
How Injectable Semaglutide Works for Weight Loss
Semaglutide injections mimic a natural hormone that signals fullness to your brain, reducing hunger and caloric intake. When you inject semaglutide once weekly under the skin, it activates GLP-1 receptors in areas of your brain that regulate appetite, energy expenditure, and blood sugar stability. This mechanism explains why patients often report feeling satisfied with smaller meals and experiencing fewer cravings throughout the day.
The medication also slows stomach emptying, which prolongs the sensation of fullness after eating. This dual action—central nervous system signaling plus gastric effects—produces meaningful weight loss in most patients. Research demonstrates that injectable semaglutide is more effective than oral formulations for achieving sustained weight reduction, making it a preferred choice for many individuals seeking rapid, measurable results.
Wegovy vs. Compounded Semaglutide Injections: Key Differences
Wegovy is a brand-name injectable semaglutide manufactured by Novo Nordisk, while PlexusDx offers compounded semaglutide prepared by licensed 503A compounding pharmacies. Both contain the identical active pharmaceutical ingredient and work through the same biological mechanism. The primary difference lies in cost: Wegovy typically costs $1,300–$1,500 per month without insurance coverage, whereas PlexusDx's compounded semaglutide injection starts at just $189/mo (or $149/mo on the 6-month plan), and your dose can increase without any price change.
Compounded medications undergo rigorous quality testing and must meet United States Pharmacopeia (USP) standards for purity, potency, and sterility. PlexusDx sources all injections from licensed 503A compounding pharmacies—never 503B facilities—ensuring pharmaceutical-grade safety. Insurance requirements differ as well: Wegovy often requires insurance approval and prior authorization, while PlexusDx requires no insurance and no membership fees, making treatment accessible to anyone in all 50 states.
Clinical Evidence Supporting Injectable Semaglutide Effectiveness
The STEP trials, a series of landmark randomized controlled studies, evaluated semaglutide injections in over 4,500 adults with obesity or overweight with weight-related conditions. Participants receiving the highest dose of semaglutide (2.4 mg weekly) experienced an average weight loss of 15.3% of their baseline body weight over 68 weeks, compared to 2.6% in the placebo group. These results represent one of the most significant weight loss outcomes ever documented in a medication trial.
Additional research shows that injectable semaglutide improves cardiovascular markers, including blood pressure, cholesterol levels, and inflammatory markers. Patients also report sustained reductions in hunger scores and improvements in quality of life. The effects remain consistent when semaglutide is sourced from licensed compounding pharmacies, as the active ingredient and delivery mechanism are identical to brand-name products.
Personalized Treatment with PlexusDx Precision Peptide Genetic Testing
Not everyone responds identically to semaglutide due to genetic variations affecting GLP-1 receptor sensitivity and metabolism. PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway genetic assessment that identifies your genetic predispositions across 14 metabolic pathways, 49 peptides, and 150+ personalized insights. Key variants like GLP1R rs6923761 influence how efficiently your body's GLP-1 receptors respond to medication, helping guide whether semaglutide injection, tirzepatide, or a dual-compound approach may work best for you.
The Precision Peptide Genetic Test costs $99 and is available as an add-on after your first month of treatment. This personalization helps PlexusDx clinicians optimize your compound selection and dosing strategy, increasing the likelihood of achieving your weight loss goals. Genetic insights also reveal whether you might benefit from the GLP-Squared Injection—a dual compound combining semaglutide and tirzepatide for enhanced results—starting at just $289 per month.
Side Effects and Safety Considerations for Injectable Semaglutide
Injectable semaglutide is generally well-tolerated, though common side effects include mild nausea, vomiting, diarrhea, and constipation, typically occurring during the dose-escalation phase. Most patients experience improved tolerability as their body adjusts over 4–6 weeks. Serious side effects are rare but include pancreatitis, severe allergic reactions, and thyroid concerns in individuals with a personal or family history of medullary thyroid cancer—a contraindication requiring careful screening before starting treatment.
PlexusDx requires a comprehensive health intake and communicates closely with your healthcare provider to monitor for any adverse reactions. Injection-site reactions are minimal and usually resolve within hours. The medication is contraindicated in pregnancy and requires careful management in patients with diabetic retinopathy or kidney disease. Your PlexusDx clinician will review all safety considerations during your initial consultation to ensure semaglutide injections are appropriate for your health profile.
How to Start Compounded Semaglutide Injections Through PlexusDx
Beginning treatment with PlexusDx takes just three simple steps: complete a brief online health intake form, receive a telehealth consultation with a licensed clinician who reviews your medical history and goals, and receive your first shipment of compounded semaglutide injection directly to your home. The entire process is completed without insurance requirements, membership fees, or lengthy prior authorization delays. HSA and FSA accounts are eligible for payment, making treatment even more affordable.
Once your prescription is approved, PlexusDx ships your medication in discrete, refrigerated packaging with detailed injection instructions and customer support available throughout your treatment. Your dose may increase over time to reach therapeutic effectiveness, but your monthly price remains flat at the starting rate you select. Follow-up consultations occur every 4–6 weeks to assess weight loss progress, tolerability, and whether genetic testing or a medication adjustment would optimize your results.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $189/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is Wegovy the only injectable semaglutide option available?
No. While Wegovy is the FDA-approved brand-name version, PlexusDx offers compounded semaglutide injections containing the identical active ingredient from licensed 503A pharmacies. Compounded semaglutide provides the same clinical effectiveness at significantly lower cost—starting at $189 per month versus $1,300+ for Wegovy—without requiring insurance approval.
How quickly does injectable semaglutide produce weight loss results?
Most patients begin noticing reduced appetite within 2–3 weeks of starting semaglutide injections. Measurable weight loss typically appears after 4–6 weeks of consistent use. Clinical trials show average weight loss of 4–5 pounds per month during the first 3 months, accelerating as doses increase to therapeutic levels over 16–20 weeks.
Does my dose increase change the price with PlexusDx?
No. PlexusDx's pricing model ensures your monthly cost remains flat regardless of dose escalation. Starting at $189 per month for compounded semaglutide injection, you may increase your dose as needed to reach optimal weight loss without any price increase—a benefit unavailable with brand-name Wegovy or insurance-based plans.
What happens if injectable semaglutide doesn't work well for me?
PlexusDx offers alternative GLP-1 and dual-compound options if semaglutide injections aren't right for you. These include oral semaglutide ($289/mo), compounded tirzepatide injection ($289/mo), or the GLP-Squared Injection combining both compounds ($289/mo). Genetic testing through the Precision Peptide Test ($99) helps identify which medication your body may respond to most effectively.
How does the Precision Peptide Genetic Test improve semaglutide results?
No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Protecting Your Progress: Do You Need to Refrigerate Your Ozempic Pen?
Navigating Air Travel with Weight Loss Medications: Can I Take Wegovy on a Plane?